Clindabuc vet. 75 mg tabletti
Clindabuc vet. 75 mg tabletti
Not authorised
- Clindamycin
Product identification
Medicine name:
Clindabuc vet. 75 mg tabletti
Active substance:
- Clindamycin
Target species:
-
Dog
-
Cat
Route of administration:
-
Oral use
Product details
Active substance and strength:
-
Clindamycin75.00milligram(s)1.00Tablet
Pharmaceutical form:
-
Tablet
Withdrawal period by route of administration:
-
Oral use
- Dog
- Cat
Anatomical therapeutic chemical veterinary (ATCvet) codes:
- QJ01FF01
Legal status of supply:
-
Veterinary medicinal product subject to veterinary prescription
Authorisation status:
-
Surrendered
Authorised in:
-
Finland
Additional information
Entitlement type:
-
Marketing Authorisation
Legal basis of product authorisation:
-
Generic (abridged application) - art 10(1)
Marketing authorisation holder:
- CEVA Sante Animale B.V.
Marketing authorisation date:
Manufacturing sites for batch release:
- Lelypharma B.V.
Responsible authority:
- Finnish Medicines Agency
Authorisation number:
- 12953
Date of authorisation status change:
To consult adverse reactions on veterinary medicinal products please go to www.adrreports.eu/vet
Documents
Summary of Product Characteristics
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/01/2022
Package Leaflet
This document does not exist in this language (English). You can find it in another language below.
Finnish (PDF)
Published on: 18/01/2022
How useful was this page?: